Fostering multidisciplinary collaboration in drug discovery

Zeynep Erden, Shiko Ben-Menahem, Georg von Krogh, Andreas Schneider, Guido Koch, Hans Widmer

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Drug discovery teams combine specialists with in-depth knowledge from a variety of scientific disciplines. Such diversity in thought worlds poses a challenging exercise in cross-disciplinary collaboration and project coordination. Based on a longitudinal field study of five projects in a leading pharmaceutical company, we present a framework outlining the conditions for effective cross-disciplinary collaboration in drug discovery teams.We show that knowledge creation in multidisciplinary teams relies on a combination of formal team structures and informal co-ordination practices. Formal team structures set the boundary conditions for cross-disciplinary co-ordination. Within these boundaries, self-managed sub-teams draw on informal coordination practices involving cross-disciplinary anticipation, synchronisation and triangulation, to overcome knowledge boundaries and high uncertainty.We identify five key insights and two questions which are important for managers to consider for fostering multidisciplinary collaboration in drug discovery.

Original languageEnglish
Pages (from-to)58-62
Number of pages5
JournalDrug Discovery World
Volume2019
Publication statusPublished - Mar 2019

Bibliographical note

Funding Information:
Management and Innovation at ETH Zürich. He is also a member of the National Research Council of the Swiss National Science Foundation (SNF).

Publisher Copyright:
© 2019 RJ Communications and Media Ltd.. All rights reserved.

Fingerprint

Dive into the research topics of 'Fostering multidisciplinary collaboration in drug discovery'. Together they form a unique fingerprint.

Cite this